These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7978890)

  • 1. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
    Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; Reubi JC; Lamberts SW
    Ann N Y Acad Sci; 1994 Sep; 733():416-24. PubMed ID: 7978890
    [No Abstract]   [Full Text] [Related]  

  • 2. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
    Pauwels S; Leners N; Fiasse R; Jamar F
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
    Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
    [No Abstract]   [Full Text] [Related]  

  • 4. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
    Chiti A; Spinelli A; Bombardieri E
    Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
    Banzo J; Abós MD; Prats E; García F; Razola P
    Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
    Modlin IM; Cornelius E; Lawton GP
    Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
    Ahlman H; Tisell LE; Wängberg B; Nilsson O; Forssell-Aronsson E; Fjälling M
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):21-8. PubMed ID: 7992076
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
    Wangberg B; Forssell-Aronsson E; Tisell LE; Nilsson O; Fjalling M; Ahlman H
    Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor: scintigraphy and radionuclide therapy.
    Krenning EP; Kooij PP; Pauwels S; Breeman WA; Postema PT; De Herder WW; Valkema R; Kwekkeboom DJ
    Digestion; 1996; 57 Suppl 1():57-61. PubMed ID: 8813472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
    Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
    Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC
    J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintigraphy of somatostatin receptors in gastropancreatic tumors].
    Mansi L
    Radiol Med; 1998 Mar; 95(3):264. PubMed ID: 9638181
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
    Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
    J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
    Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; de Herder WW; Reubi JC; Lamberts SW
    Digestion; 1994; 55 Suppl 3():54-9. PubMed ID: 7698538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).
    Olsen JO; Pozderac RV; Hinkle G; Hill T; O'Dorisio TM; Schirmer WJ; Ellison EC; O'Dorisio MS
    Semin Nucl Med; 1995 Jul; 25(3):251-61. PubMed ID: 7570044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
    Janson ET; Kälkner KM; Eriksson B; Westlin JE; Oberg K
    Nucl Med Biol; 1999 Nov; 26(8):877-82. PubMed ID: 10708300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor imaging.
    Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium 111 octreotide scintigraphy in angiofibroma.
    Guneri EA; Degirmenci B; Durak H; Ikiz AO; Derebek E; Sutay S
    Otolaryngol Head Neck Surg; 1998 Jan; 118(1):137-9. PubMed ID: 9450844
    [No Abstract]   [Full Text] [Related]  

  • 20. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
    Anderson CJ; Dehdashti F; Cutler PD; Schwarz SW; Laforest R; Bass LA; Lewis JS; McCarthy DW
    J Nucl Med; 2001 Feb; 42(2):213-21. PubMed ID: 11216519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.